B96.5 Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere

Name of the Condition

• Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere

Summary

This code is used to identify conditions where Pseudomonas aeruginosa, Pseudomonas mallei, or Pseudomonas pseudomallei is identified as the underlying cause of a disease that is classified elsewhere in the ICD-10-CM system. The bacteria are not the primary focus of the disease but contribute to its development or exacerbation. This code is applied when the specific bacterial agent is known but the primary disease is categorized under a different code.

Causes

The causes are attributed to Pseudomonas aeruginosa, Pseudomonas mallei, or Pseudomonas pseudomallei, which are gram-negative bacteria. These organisms can act as opportunistic pathogens, colonizing various body sites and causing infections, particularly in individuals with compromised immunity or underlying conditions. They may be acquired through environmental exposure, healthcare settings, or contact with contaminated sources.

Risk Factors

• Underlying chronic conditions that weaken the immune system, such as cystic fibrosis or diabetes.
• Recent antibiotic use, which may disrupt normal flora and allow bacterial overgrowth.
• Invasive medical procedures that introduce bacteria into sterile areas.
• Prolonged hospitalization, increasing exposure to healthcare-associated bacteria.
• Age extremes (very young or elderly), where immune function is typically reduced.
• Exposure to contaminated water or soil, particularly for Pseudomonas pseudomallei.

Symptoms

Symptoms vary depending on the primary disease and the site of infection. Common manifestations may include fever, localized pain, or signs of infection at the affected area. For example, respiratory infections may present with cough or shortness of breath, while skin infections may show redness, swelling, or discharge.

Diagnosis

Diagnosis involves identifying the specific Pseudomonas species through clinical or laboratory findings. This may include culturing samples from the infection site, using molecular testing (e.g., PCR) to detect bacterial DNA, or performing antimicrobial susceptibility testing to guide treatment. Clinical correlation with the patient's symptoms and history is essential.

Treatment Options

Treatment typically involves targeted antibiotic therapy based on susceptibility results. Commonly used antibiotics include antipseudomonal penicillins, cephalosporins, or fluoroquinolones. In severe cases, combination therapy or intravenous antibiotics may be necessary. Supportive care, such as managing fever or pain, may also be provided.

Prognosis and Follow-Up

Prognosis depends on the severity of the underlying disease, the patient's immune status, and the timeliness of treatment. Early intervention improves outcomes, but severe infections or those in immunocompromised individuals may have higher morbidity. Follow-up may involve monitoring for resolution of symptoms, repeat cultures, or adjusting antibiotics based on response.

Complications

Complications can include sepsis, organ damage from infection, or antibiotic resistance. Infections may spread to other body sites, leading to more severe illness. Chronic infections, particularly in patients with cystic fibrosis, may require long-term management.

Lifestyle & Prevention

Preventive measures include practicing good hygiene, avoiding contaminated water or soil, and ensuring proper wound care. In healthcare settings, strict infection control protocols (e.g., hand hygiene, sterilization) reduce the risk of transmission. For high-risk individuals, avoiding exposure to potential sources of Pseudomonas is important.

When to Seek Professional Help

Seek medical attention if symptoms of infection worsen, such as increasing pain, fever, or signs of systemic illness (e.g., confusion, rapid heart rate). Prompt evaluation is critical for immunocompromised individuals or those with chronic conditions, as early treatment improves outcomes.

Tips for Medical Coders

This code is assigned when Pseudomonas aeruginosa, Pseudomonas mallei, or Pseudomonas pseudomallei is documented as the cause of a disease classified elsewhere. Ensure the specific species is identified in the medical record, and the primary disease is coded separately. Documentation should clearly link the bacterial agent to the underlying condition to justify code assignment.